A practical approach to febrile cancer patients:  Diagnostic stewardship in Oncology units

A practical approach to febrile cancer... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/13-997" }, "headline": "A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units", "datePublished": "2024-09-02T16:03:41", "dateModified": "2024-10-16T15:57:12", "author": [ { "@type": "Person", "name": "Sridevi H.B." }, { "@type": "Person", "name": "Anisha Maria Fernandes" }, { "@type": "Person", "name": "Sanyo D'souza" }, { "@type": "Person", "name": "Prashantha B." }, { "@type": "Person", "name": "Pooja Rao" }, { "@type": "Person", "name": "Suchitra Shenoy M" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": " Introduction Cancer and cytotoxic chemotherapy used for its treatment predispose to severe and often fatal infections. Prompt diagnosis and timely antibiotic therapy are crucial, with delays in therapy initiation having high mortality. Complete blood count (CBC) is an inexpensive, standardized, and preliminary investigation for the management and follow-up of cancer patients with diagnostic and prognostic value. Method We studied the types of infections associated with various cancers treated with chemotherapy, their etiologies and susceptibility patterns, and the hematological profile of these patients as predictors of infection. Results A total of 21 patients (12 solid and 9 hematological malignancies) presented with 31 febrile episodes. White Blood cell count (2079 cells/cu. mm), percentage of neutrophils (52.9%), absolute neutrophil (137.5 cells/cu. mm), and platelet count (1,77,507 cells/cu. mm) were significantly lower in the 11 patients with febrile neutropenia. The absolute lymphocyte count (412.7 cells/cu. mm) was reduced with a strikingly low Neutrophil-to-lymphocyte ratio (NLR) (6.07) in patients with neutropenia. Laboratory and radiological evidence were present in 14/15 episodes of hematological malignancies (p-0.218) whereas unexplained clinical sepsis was common in solid malignancies (p-0.0202). The majority of documented infections were bacterial, caused by gram-negative bacilli, often showing multi-drug resistance. Infectious etiologies were identified in 71.4% of the patients with febrile neutropenia for >5days. Bacterial infections developed within 2 days of neutropenia, whereas viral and fungal infections manifested in prolonged neutropenia. Multi-site infections and higher mortality rates were observed in patients with febrile neutropenia. (p<0.04) Conclusion Febrile neutropenia is a common complication among patients receiving chemotherapy for cancer, with an increased risk of morbidity and mortality. Early, rapid, and accurate diagnosis is key to prompt intervention. Hematological parameters such as Total Leukocyte count, platelet count, NLR, and Platelet-to-lymphocyte ratio are promising biomarkers in conjunction with morphological changes in neutrophils, thus proving that CBC and peripheral smears are simple, easily available, cost-effective, and highly dependable screening tools, especially in resource-poor settings. " } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/13-997/v2", "name": "A practical approach to febrile cancer patients: Diagnostic stewardship..." } } ] } Home Browse A practical approach to febrile cancer patients: Diagnostic stewardship... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article H.B. S, Fernandes AM, D'souza S et al. A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.12688/f1000research.154812.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Research Article Revised A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] Sridevi H.B. https://orcid.org/0000-0001-5325-7086 1 , Anisha Maria Fernandes https://orcid.org/0000-0002-0374-975X 2 , Sanyo D'souza 3 , Prashantha B. 4 , Pooja Rao https://orcid.org/0000-0003-0717-783X 2 , Suchitra Shenoy M https://orcid.org/0000-0003-1425-0097 2 Sridevi H.B. https://orcid.org/0000-0001-5325-7086 1 , Anisha Maria Fernandes https://orcid.org/0000-0002-0374-975X 2 , [...] Sanyo D'souza 3 , Prashantha B. 4 , Pooja Rao https://orcid.org/0000-0003-0717-783X 2 , Suchitra Shenoy M https://orcid.org/0000-0003-1425-0097 2 PUBLISHED 16 Oct 2024 Author details Author details 1 Department of Pathology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India 2 Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India 3 Department of Medical Oncology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India 4 Department of General Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India Sridevi H.B. Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Anisha Maria Fernandes Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Sanyo D'souza Roles: Data Curation, Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Prashantha B. Roles: Data Curation, Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Pooja Rao Roles: Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Suchitra Shenoy M Roles: Conceptualization, Formal Analysis, Methodology, Supervision, Validation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS This article is included in the Manipal Academy of Higher Education gateway. Abstract Introduction Cancer and cytotoxic chemotherapy used for its treatment predispose to severe and often fatal infections. Prompt diagnosis and timely antibiotic therapy are crucial, with delays in therapy initiation having high mortality. Complete blood count (CBC) is an inexpensive, standardized, and preliminary investigation for the management and follow-up of cancer patients with diagnostic and prognostic value. Method We studied the types of infections associated with various cancers treated with chemotherapy, their etiologies and susceptibility patterns, and the hematological profile of these patients as predictors of infection. Results A total of 21 patients (12 solid and 9 hematological malignancies) presented with 31 febrile episodes. White Blood cell count (2079 cells/cu. mm), percentage of neutrophils (52.9%), absolute neutrophil (137.5 cells/cu. mm), and platelet count (1,77,507 cells/cu. mm) were significantly lower in the 11 patients with febrile neutropenia. The absolute lymphocyte count (412.7 cells/cu. mm) was reduced with a strikingly low Neutrophil-to-lymphocyte ratio (NLR) (6.07) in patients with neutropenia. Laboratory and radiological evidence were present in 14/15 episodes of hematological malignancies (p-0.218) whereas unexplained clinical sepsis was common in solid malignancies (p-0.0202). The majority of documented infections were bacterial, caused by gram-negative bacilli, often showing multi-drug resistance. Infectious etiologies were identified in 71.4% of the patients with febrile neutropenia for >5days. Bacterial infections developed within 2 days of neutropenia, whereas viral and fungal infections manifested in prolonged neutropenia. Multi-site infections and higher mortality rates were observed in patients with febrile neutropenia. (p<0.04) Conclusion Febrile neutropenia is a common complication among patients receiving chemotherapy for cancer, with an increased risk of morbidity and mortality. Early, rapid, and accurate diagnosis is key to prompt intervention. Hematological parameters such as Total Leukocyte count, platelet count, NLR, and Platelet-to-lymphocyte ratio are promising biomarkers in conjunction with morphological changes in neutrophils, thus proving that CBC and peripheral smears are simple, easily available, cost-effective, and highly dependable screening tools, especially in resource-poor settings. READ ALL READ LESS Keywords Oncology, Complete Blood Counts (CBC), Diagnostic stewardship, infections Corresponding Author(s) Anisha Maria Fernandes ( [email protected] ) Close Corresponding author: Anisha Maria Fernandes Competing interests: No competing interests were disclosed. Grant information: The author(s) declared that no grants were involved in supporting this work. Copyright: © 2024 H.B. S et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: H.B. S, Fernandes AM, D'souza S et al. A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.12688/f1000research.154812.2 ) First published: 02 Sep 2024, 13 :997 ( https://doi.org/10.12688/f1000research.154812.1 ) Latest published: 16 Oct 2024, 13 :997 ( https://doi.org/10.12688/f1000research.154812.2 ) Revised Amendments from Version 1 In response to the reviewer’s comments the following additions have been made: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF or Taxane-induced Pseudo-Pelger Huet anomaly. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. In response to the reviewer’s comments the following additions have been made: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF or Taxane-induced Pseudo-Pelger Huet anomaly. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. See the authors' detailed response to the review by Jayashree Kulkarni See the authors' detailed response to the review by Dr Monali Gupta READ REVIEWER RESPONSES Introduction Better outcomes in cancer patients are seen with advancements in management using more aggressive and tailored regimens. Infections, however, continue to be a major cause of morbidity and mortality in cancer patients. 1 Immunosuppression due to malignancy as well as therapeutic modalities increase an individual’s susceptibility to infections. In hematological malignancies, the underlying immune deficiencies and myelosuppressive treatments are major contributing factors. 2 Obstruction, disruption of anatomical barriers and surgical interventions are additional risk factors for infections in solid tumours. 3 Apart from cytotoxic chemotherapy, radiotherapy and the use of medical devices such as catheter, stents and prosthesis carry an increased risk. 3 Common sites of infection are the blood stream, urinary tract, respiratory tract, and skin and soft tissue. Severe and persistent neutropenia, especially absolute neutrophil counts (ANC) <100 cells/ml, exponentially increases the risk of severe infections with bacterial, fungal, viral, and parasitic agents. 2 , 3 Bacterial infections are the most common and are often polymicrobial. 2 , 3 Studies from India, including one from our own center, show that infections are predominantly due to gram-negative bacilli. The increased incidence of multidrug-resistant organisms complicates its management. 4 – 7 A complete blood count (CBC) with peripheral smear examination is an important tool for monitoring patients undergoing chemotherapy. White blood cell (WBC) analysis is commonly used to investigate the risk of infection; however, in patients undergoing chemotherapy, it becomes challenging as the total WBC count is low and neutropenia may be observed. Infections stimulate the production of cytokines which in turn stimulates the production of immature granulocytes from marrow and this can be evidenced as ‘left shift’ in the smear examination. Toxicity changes in neutrophils in the form of toxic granules and vacuoles are observed in patients with infection. Absolute leukocyte counts, such as absolute neutrophil count, absolute monocyte count, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet parameters such as plateletcrit (PCT), platelet distribution width (PDW), and mean platelet volume (MPV), have been extensively studied in predicting infections. 8 – 10 Increased mortality rates are observed when initial therapy with inappropriate antibiotics is initiated, even if the regimen is adjusted later based on microbiological investigations. 11 Early diagnosis with prompt and appropriate antibiotics ensures favorable outcomes. A robust diagnostic and antimicrobial stewardship program could guide oncologists and physicians in timely and effective empirical therapy. Our study aimed to study the types of infections in patients with cancer undergoing chemotherapy, to identify the association of infections with specific cancers, the etiological agents, and their antimicrobial susceptibility profile, and to study the hematological profile of patients receiving chemotherapy during a febrile episode. Methods In this prospective study, over a 1-year period, from August 2021 to July 2022, all cancer patients admitted to two of our tertiary care centers with signs and symptoms of infection were included. Patients on targeted therapies or immunomodulators, radiotherapy or post-stem cell transplant, and immediate post-surgical (<30 days postoperative) were excluded from the study. The study was approved by the Institutional Ethics Committee of Kasturba Medical College, Mangalore (Reg No. ECR/541/Inst/KA/2014/RR-20) (DHR Reg. No. EC/NEW/INST/2020/742) on 22.07.2021 and assigned the protocol number IEC KMC MLR-07/2021/230. The committee permitted a waiver of consent to participate from the patients as patient details and data were sourced from the case files and there is no direct contact between the researcher and participant. The patients were monitored for markers of infection with complete blood count (CBC) and C-reactive protein (CRP). Peripheral blood samples from the cases were studied using the Coulter ® DXH800 hematology analyzer (Beckman Coulter Inc., Miami, FL, USA). The CBC parameters included hemoglobin (Hb), total leukocyte count (TLC), platelet count (PLT), and differential leukocyte count (DLC). The neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) were calculated using the absolute neutrophil count, absolute lymphocyte count, and platelet count. The peripheral smear stained with Leishman stain was used for morphological assessment of any evidence of infections, such as toxic changes, toxic granules, presence of immature granulocytes, presence of any virus-induced reactive lymphocytes, monocytosis, intracellular organisms, and/or hemoparasites. The immature granulocytes were calculated manually from a detailed peripheral smear examination. Microbiological investigations were based on the clinical presentation, and an appropriate sample was collected. These investigations included microscopy, culture, serological tests, and molecular assays. Microscopy included Gram staining, Auramine-O staining, and KOH mounting. The culture was performed according to standard microbiological techniques for bacteria and fungi. Automated culture systems included the BacT/ALERT system (BioMerieux®, TM USA) for blood and sterile body fluids and MGIT (BD BACTEC® TM ) for suspected mycobacterial infections. Identification of the bacteria and yeasts, and antimicrobial susceptibility testing of the isolates were performed using the VITEK 2 Compact system (BioMerieux®, TM France), and minimum inhibitory concentration (MIC) was interpreted using the Clinical and Laboratory Standards Institute (CLSI) 12 guidelines. Serological and molecular tests were performed according to the clinician’s request. Demographic and clinical data were extracted from the medical records, including the type of cancer, cancer treatment, clinical presentation, laboratory investigations, radiology findings, use of antibiotic/antifungal treatment, and outcome. Episodes of Febrile Neutropenia (FN) have been documented. FN was diagnosed in the presence of a single oral temperature of ≥38.3°C (101 °F) or 38.0°C (100.4 °F) for more than 1 h along with an absolute neutrophil count (ANC) ≤500/μl or ≤1000/μl with predicted rapid decline during the next 48hr. 7 The collected data were entered into MS Excel, analyzed, and presented in the form of tables, pie charts, and bar diagrams. The Mann-Whitney U test was used to assess the statistical differences between the neutropenic and non-neutropenic groups, and the chi-square test was used to analyze the distribution of categorical variables. All data were analyzed using JAMOVI software version 2.4.14. Statistical significance was set at p <0.05. Results The study included 21 patients with solid or hematological malignancies, with a total of 31 febrile episodes. The mean age of the patients was 53.3 years with a male-to-female ratio of 3:1 (15 males and 6 females). There were 12 solid malignancies and 9 hematological neoplasms. Table 1 shows the various types of malignancies and distribution of cases presenting with febrile episodes. Table 1. Various types of malignancies and distribution of cases presenting with febrile episodes. Solid/Hematological Neoplasm Final Diagnosis Total Number of cases Solid malignancies 12 cases Esophagus SCC 1 Testes Mixed GCT with metastasis 1 Rectum Adenocarcinoma with metastasis 1 Bone Osteosarcoma 1 Breast IDC 1 Lung Adenocarcinoma-Metastatic 1 Lung SCC 1 Breast IDC 1 Ovary Recurrent Serous ovarian carcinoma 1 Bone-Pelvis Ewing’s sarcoma/PNET 1 Sigmoid colon Adenocarcinoma 1 Ca colon Adenocarcinoma 1 Hematological malignancies 9 cases Thymus T-LBL 1 Lymphoma Follicular 1 CML Blast crisis CML Blast crisis 1 HG B-NHL HG-B-NHL 1 Pre-B ALL Pre-B-ALL, BCR/ABL + 1 Lymphoma DLBCL 1 Lymphoma DLBCL 1 AML AML 1 AML AML 1 Febrile episodes in hematological malignancies were noted in older individuals compared to solid malignancies. There was a striking male predominance across all types of malignancy, presenting with febrile episodes. Table 2 shows the demographic and hematological profiles of the patients. Table 2. Demographics and the hematological profiles of solid and hematological malignancy cases. Parameters All febrile episodes Solid Malignancy Hematological Malignancy p value Total no. of episodes 31 episodes 16 episodes 15 episodes - Age in years 54.5 (29-79) 48.4 (29-73) 60 (38-79) 0.11 Gender 3:1 2:1 3.5:1 0.612 FN episodes 11 episodes 6 episodes 5 episodes 0.809 Hemoglobin (gm/dL) 9.9 (6.6-13.5) 10.4 (8.1-12.9) 9.42 (6.6-13.5) 0.928 WBC count (cells/cu. mm) 8,034 (100-72,200) 5018.75 (100-19,200) 11,251.33 (100-72,200) 0.522 Neutrophil (%) 53.5 (1.4-94.4) 54.69 (4-94.4) 52.15 (2-88.6) 0.301 Lymphocyte (%) 30.0 (3.2-97.7) 32.63 (3.2-79.9) 27.22 (7-97.7) 0.323 Eosinophils (%) 1.7 (0-7) 2.02 (0-7) 1.42 (0-1.2) 0.097 Monocytes (%) 9.1 (0-25.5) 9.96 (0.8-25) 8.11 (0.1-25.5) 0.077 Basophils (%) 0.61 (0-4.2) 0.75 (0-4.2) 0.47 (0-0.9) 0.110 Left shift ( Figure 1 ) 11 cases 6/16 episodes 5/15 cases 0.810 Toxic granules ( Figure 1 ) 4 cases 2/16 episodes 2/15 cases 0.944 Absolute Neutrophil count (ANC) (cells/cu. mm) 4402.39 (12-18,124) 3877.25 (12-18,124) 4962.53 (14-15,162) 0.186 Absolute Leucocyte count (ALC) (cells/cu. mm) 909.44 (0-1905) 660.01 (96-1382.4) 1175.42 (73.8-5054) 0.151 Neutrophil lymphocyte ratio (NLR) 5.73 (0.01-29.49) 5.27 (0.11-29.49) 6.21 (0.01-26.84) 0.492 Platelet lymphocyte ratio (PLR) 307.23 (3.95-1121.24) 339.13 (106.7-1121.24) 273.20 (3.95-1025.07) 0.140 Platelets (cells/cu.mm) 1,67,490 (7000-55200) 1,80,875 (7000-552000) 15,3213.30 (20000-422000) 0.086 Microbiological evidence of infection 15 5 10 0.0244 * Diagnosis based on radiological/other lab findings 9 5 4 0.389 Unexplained clinical sepsis 7 6 1 0.0202 * * p <0.05, and statistically significant. Figure 1. Peripheral smear findings: A: Toxic granules in neutrophils; B: Left shift; C: Toxic vacuolation in neutrophils. There were a total of 11 febrile neutropenic episodes, of which 6 episodes were in solid malignancies [1 episode in IDC case, 1 in metastatic seminoma, 3 in bone tumors, and 1 in esophageal SCC], and 5 were in hematological malignancies [1 in LBL, 1 in ALL, 2 episodes in AML and one in DLBCL cases]. Table 3 shows the differences in the demographics and hematological profiles of febrile neutropenic and febrile non-neutropenic patients. Table 3. Demographics and hematological profile of febrile neutropenic and febrile non-neutropenic patients. Parameters Febrile neutropenic episodes Febrile non-neutropenic episodes p value Total no. of episodes 11 episodes 20 episodes Age in years 50.8 years 58.3 years 0.12602 Gender 3.5:1 2.25:1 0.472. Relative risk 6.83 Hemoglobin (gm/dL) 9.7 10.1 0.5892 WBC count (cells/cu. mm) 2079.1 11,310 0.00008* Neutrophil (%) 21.3 71.1 < .00001* Lymphocyte (%) 59.6 13.74 0.00026* Eosinophils (%) 2.3 1.39 0.1074 Monocytes (%) 7.9 9.7 0.30302 Basophils (%) 0.7 0.5 0.90448 Left shift 6/11 5/20 0.099 ANC (cells/cu. mm) 137.5 6748.1 < .00001* ALC (cells/cu. mm) 435.5 1170.1 < .00001* NLR 0.6 8.6 < .00001* PLR 399.5 256.5 0.98404 Platelets (cells/cu. mm) 81,181 2,14,960 0.0043* Fatalities 3/11 1/20 0.0384* Laboratory + Radiological evidence of infection 7 17 0.17346 Unexplained clinical fever 4 3 WBC count, percentage of neutrophils, and absolute neutrophil and platelet counts were significantly lower in febrile neutropenic patients. Additionally, the absolute lymphocyte count was reduced, with a strikingly lower NLR ratio in patients with neutropenia than in those without neutropenia. However, there were no statistical differences in the CBC parameters of febrile episodes between solid and hematological malignancies. Among the 31 febrile episodes during the study period, 16 episodes were observed in patients with solid organ tumors and 15 febrile episodes were observed in patients with hematological malignancies. Infectious etiology was documented with microbiological evidence in 15 episodes (48.4%) and supportive radiological or laboratory evidence in nine episodes (29.0%). Seven episodes (22.6%) were unexplained and were documented as clinical sepsis. Microbiological evidence of infections was available in 10/15 febrile episodes in hematological malignancies compared to 5/16 febrile episodes in solid malignancies, which was statistically significant. Laboratory evidence, including radiological evidence, was present in 14/15 episodes in hematological malignancies compared to 10/16 episodes in solid malignancies, with a significant p-value of 0.0218. Unexplained clinical sepsis was statistically more common in solid malignancies (6/16 episodes) than in hematological malignancies (1/15). Of the 18 bacterial infections, 15 showed documented microbiological evidence. Fungal and viral etiology was suspected in four episodes each, with microbiological confirmation of fungal etiology in two episodes (invasive aspergillosis) and viral etiology (SARS CoV-2) in one episode. Polymicrobial infections were noted in two episodes (6.5%). Infectious etiologies were identified in 71.4% of patients with febrile neutropenia for > 5 days, whereas there was no confirmed laboratory diagnosis in 75% of patients with febrile neutropenia for ≤ 4 days. On average, bacterial infections were found to develop within 2 days following the development of neutropenia, whereas viral and fungal infections usually manifested if neutropenia persisted for 5 and >7 days, respectively. Urinary tract infections accounted for 50% of the episodes, with respiratory tract infections (RTI), bloodstream infections (BSI), and skin and soft tissue infections (SSTI) in 37.5%, 20.8%, and 20.8% of the episodes, respectively. Multi-site infections were observed in four episodes (16.7%), of which three episodes were noted in patients with febrile neutropenia (p = 0.03). Urinary tract infections were the most common infections observed in patients with hematological malignancies (41.7%) and solid organ tumors (36.8%). Eighty % of BSI and 67% of RTI were observed in patients with hematological malignancies. Most infections were caused by gram-negative bacilli (72.2%), with E. coli being the most common (69.2%). Enterococcus faecalis was observed in 80% of the infections caused by gram-positive cocci. All E. coli isolates were ESBL producers, and carbapenem resistance was observed in 100% of the Acinetobacter baumannii isolates and 50% of the Klebsiella pneumoniae isolates. All E. faecalis isolates were sensitive to beta-lactams, whereas all Enterococcus faecium isolates were vancomycin-resistant. Mortality rates were significantly higher in patients with neutropenia than in those without neutropenia (p = 0.0384). Sixty-seven percent of fatalities among febrile neutropenia episodes had a prolonged neutropenia duration of > 12 days. Among fatalities, 75% were observed among patients with hematological malignancies, all of whom had bacterial infections with positive cultures. Discussion Neutropenia is one of the most important risk factors for infection in cancer patients. The degree and duration of neutropenia corresponds to the severity of infection. Infection rates are inversely proportional to the absolute neutrophil count, with the highest incidence of infection seen with ANC 7 days), 3 , 13 with a high risk of fungal infections. In our study, we did not observe a preponderance of infections during episodes of febrile neutropenia; however, multi-site infections were significantly more likely to occur. Infectious etiologies were identified in 75% of episodes with a longer duration of neutropenia. All cases of fungal pneumonia developed after prolonged neutropenia for more than a week and were caused by Aspergillus spp. Bacterial infections are the most common type of infections in patients with cancer. ESKAPE ( Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginos a, and Enterobacter spp.) pathogens are prominent in bacterial infections and antibiotic resistance in cancer patients. 14 Gram negative bacilli accounted for 72.2% of infections, with similar rates reported in other studies. 5 , 15 In a study conducted by Bhat et al. , 5 Pseudomonas aeruginosa and Klebsiella pneumoniae were among the top gram-negative bacilli that cause infections. E. coli was the etiological agent in 50% of the infections we reported, responsible for 66.7% of UTI cases. The same study 5 reported only 14.7% infections due to E. coli , but similar rates (69.9%) of UTI. Fungal infections are associated with indwelling devices and are often polymicrobial in nature. Prophylactic agents against Candid a spp. in patients with hematological malignancies have resulted in a surge in Aspergillus spp. infections. 13 As seen in our study, pneumonia in hematological malignancies is the most common presentation of aspergillosis. The risk of viral infections increases with T cell suppression rather than neutropenia. Immunosuppression during intensive chemotherapy predisposes patients to RTI. Reactivation of HSV, VZV, HBV, CMV, and EBV has been reported. 13 Data published during the COVID-19 pandemic showed that cancer patients were more susceptible, with worse outcomes, including long COVID. 16 75% of patients with viral infections presented with RTI. Although our study was performed during the pandemic, we surprisingly reported only one diagnosed case of SARS CoV-2, reflecting how the pandemic hindered patient follow-up. The patient developed a fatal secondary bacterial infection shortly thereafter. A study by Hemel et al., 16 noted that cancer patients present with few symptoms of COVID-19 as immunosuppressants administered reduce the clinical severity, suggesting an alternative theory for the low rates of COVID infections in the study. We observed a single case of clinically diagnosed HSV. A previous study at our center, 5 revealed that BSI was the most common infection (33.3%) in both hematological and solid malignancies. In contrast, our data showed that 50% of all enrolled patients presented with UTI, followed by RTI (37.5%). A study by Campos et al. , 17 reported a similar spectrum of infections in patients with solid malignancies. BSI is more common in Hematological malignancies, 6 , 14 , 15 as seen in 80% of our patients with bacteremia. A surge in polymicrobial infections has been reported in multiple studies, 3 , 5 however we report a low incidence of 6.7%. The global increase in drug resistance among gram-negative organisms is alarming. 5 , 6 , 13 – 15 All the gram-negative isolates in our study were multidrug resistant, with 69.2% ESBLs and 23.1% carbapenem-resistant organisms (CROs). A study evaluating BSIs in malignancies 15 showed similar rates of resistance. They reported a higher mortality rate in drug-resistant gram-positive infections, which we did not observe in this study. Unexplained fevers in cancer pose a challenge for clinicians. Hematological biomarkers have been increasingly used as both diagnostic and predictive factors in various medical conditions, especially in oncology and infectious conditions. Morphological changes in neutrophils in the form of changes in their shape, size, and internal complexity, with functional deviations in the form of deformability and disturbances in motility, have been detected in sepsis. 18 Complete blood count analysis with morphological assessment of leukocytes plays a pivotal role in diagnosing sepsis. Harada et al. , 19 in his study documented a band form percentage of >10% was correlated with an increased risk of bacteremia. Left shift of granulocytes with increased number of band forms, myelocytes, and metamyelocytes can be used as a screening modality, which additionally has prognostic significance in sepsis. 20 In the present study, left shift with the presence of immature granulocytes was noted more frequently in patients with solid malignancies than in those with hematological malignancies. However, the left shift was not statistically significant between the two groups or between febrile neutropenic and febrile non-neutropenic cases. In addition, we observed morphological changes in oncology patients with multiple febrile episodes. This re-emphasizes the importance of a simple ancient method of analyzing leukocyte morphology by peripheral smear examination in the early detection of sepsis. It can be a boon, especially in resource-limited centers where advanced diagnostic facilities are unavailable. 21 It is prudent to distinguish the toxic granules in the neutrophils due to infection from that of G-CSF in cancer patients. Subtle differences could help differentiate the two. The toxic granulation secondary to infection are dark coloured ranging from dark blue to dark black whereas those secondary to G-CSF are larger and purple coloured. The granulation caused by G-CSF is generally florid with large and more numerous granules having increased staining density that are noticed in almost all neutrophils as compared to infection induced granules. Pseudo-Pelger-Huet anomaly is an acquired neutrophil change noted in patient taking medications for transplant, cancer drugs etc. Presence of PPHA may pose diagnostic challenge in patients with history of cancer therapy and associated cytopenias to differentiate from myelodysplastic neoplasm associated Pelger-Huet anamoly. Careful peripheral smear examination for other features associated with MDS with clinical correlation is mandatory to differentiate. 22 Additionally, oncology patients receiving chemotherapy can have neutropenia, lymphopenia, and thrombocytopenia, which further compromises host immunity and hence increases the incidence of bacterial infections in such patients. 23 The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios have emerged as promising biomarkers in cancer-related particulars. 24 , 25 Zahorec et al. in 2001, were the first to propose neutrophil-to-lymphocyte ratio (NLR) as an important additional marker of infection in clinical practice which is directly proportional to disease severity. 26 , 27 More and more evidences are there proving NLR to be an independent predictor of poor survival in cancer patients. A study performed by Salciccioli JD et al. showed association of NLR with clinical progression of sepsis where NLR measure at the time of ICU admission was related to higher 28-day mortality and some studies have linked NLR and platelet-to-lymphocyte ratio (PLR) with short term or long-term mortality in sepsis. 28 – 31 Thus, proving these ratios to be a simple, cost effective and feasible biomarkers of sepsis in clinical practice. In solid malignancies, NLR and PLR parameters can be utilized in correlation with tumor size-node-metastasis (TNM) staging. The inflammatory cells and their mediators play a pivotal role in development and progression of neoplasms. Chemotherapy directly affects inflammatory cell and immune cells where recovery may be different from individual to individual and post-therapy changes affect the disseminated metastatic cell expression. Lymphocytes and neutrophil have an important role in tumor immune surveillance and can directly control the growth of cancer by cytotoxic activity and apoptosis by lymphocytes and suppression of cytolytic activity of immune cells by neutrophils. Neutrophils also secrete growth promoting factors in cancer. On the other side, platelets also secrete growth factors promoting proliferation and neoangiogenesis. 32 – 34 Thus, studying NLR and PLR can be of importance in assessing the poor prognosis in many cancers. 35 , 36 A meta-analysis covering 100 studies has stated that increased NLR is associated with adverse survival in numerous solid malignancies. 37 A lower NLR is an independent factor associated with high mortality and morbidity in sepsis. 38 Similar utility of NLR in predicting febrile neutropenia in cancer patients on chemotherapy and associated increased mortality and morbidity risk has been documented. 39 , 40 Variations of NLR values in accurately diagnosing bacteremia can be attributed to inflammatory response, marrow metastasis, infections, chemotherapy and associated hematological and lymphatic disorders. 23 A study by Hwang et al., 38 in 2016 on 1395 patients, showed that initial NLR and subsequent persistent low or high values of NLR is a risk factor for predicting 28-day mortality with its increased diagnostic accuracy predicting sepsis in cancer patients. We observed a lower NLR in the patients with FN. In the present study, PLR was higher in the febrile neutropenia group. Shen et al. , in a study of 5537 patients with sepsis, documented PLR as a prognostic biomarker for increased mortality. 24 Increased PLR is negatively associated with overall survival (OS) and can provide information on the therapeutic effectiveness of chemotherapy in solid malignancies. 37 In conclusion, febrile neutropenia is a common complication with a high risk of morbidity and mortality among patients undergoing chemotherapy for malignancies. Multiple factors determine the patient's outcome, including the microbiological spectrum. Clinicians must understand the immune defects associated with specific cancers and their chemotherapy to anticipate infections. Appropriate antibiotics, both empirical and regimens tailored to the microbiology report, greatly reduce morbidity and mortality, especially considering the growing concern of multidrug resistance. Diagnostic modalities continue to evolve but are limited with respect to the spectrum of infections, cost, and availability. Early and rapid diagnosis remains the key to prompt intervention, for which reliable biomarkers are needed. Hematological parameters, such as TLC, platelet count, NLR, and PLR, are promising tools. These parameters were integrated with peripheral smear examination to look for morphological changes notably in neutrophils, and the presence of immature granulocytes continues to be a simple, easily available, cost-effective, and highly dependable screening tool, especially in resource-poor settings. Ethics and consent Approval for this study was obtained from the Institutional Ethics Committee (Kasturba Medical College, Mangalore), Reg No. ECR/541/Inst/KA/2014/RR-20, DHR Reg. No. EC/NEW/INST/2020/742. The approval was given on 22.07.2021 with protocol number IEC KMC MLR-07/2021/230. The committee permitted a waiver of consent to participate from the patients as patient details and data were sourced from the case files and there is no direct contact between the researcher and participant. Link for Peer review https://datadryad.org/stash/share/mDwqq0ZbZTXjIysjMD04gccBEV_Eg6TYwS5LRcsTEwI Data availability statement Underlying data Data excel sheet for “ A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units ” https://doi.org/10.5061/dryad.7sqv9s51w 41 This project contains the following underlying data: • Dryad_Data_Collection.xlsx • README_file.txt.txt (The file includes the title with the authors who have made contributions to the study, duration, location, funding and sharing and access information) Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication). References 1. Kochanek M, Schalk E, von Bergwelt-Baildon M , et al. : Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann. Hematol. 2019 May; 98 (5): 1051–1069. PubMed Abstract | Publisher Full Text | Free Full Text 2. Rolston KV: Infections in cancer patients with solid tumors: a review. Infect. Dis. Ther. 2017 Mar 1; 6 (1): 69–83. PubMed Abstract | Publisher Full Text | Free Full Text 3. Safdar A, Armstrong D: Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin. Infect. Dis. 2011 Oct 15; 53 (8): 798–806. PubMed Abstract | Publisher Full Text 4. Girmenia C, Menichetti F: Current epidemiology and prevention of infectious complications in cancer patients. Journal-Current Epidemiology and Prevention of Infectious Complications in Cancer Patients. 2011; 07 : 270. Publisher Full Text 5. Bhat S, Muthunatarajan S, Mulki SS, et al. : Bacterial Infection among Cancer Patients: Analysis of Isolates and Antibiotic Sensitivity Pattern. Int. J. Microbiol. 2021; 2021 (1): 1–7. Publisher Full Text 6. Mangaraj O, Barkataki D, Mohan DG: Gram negative bacilli causing blood stream infection in febrile neutropenic patients in a tertiary care centre. Int. J. Contemp. Med. Res. 2017; 4 (7): 1599–1603. 7. Carvalho AS, Lagana D, Catford J, et al. : Bloodstream infections in neutropenic patients with haematological malignancies. Infect. Dis. Health. 2020 Feb 1; 25 (1): 22–29. Publisher Full Text 8. Lee S, Oh SY, Kim SH, et al. : Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013; 13 : 350. PubMed Abstract | Publisher Full Text | Free Full Text 9. Farkas JD: The complete blood count to diagnose septic shock. J. Thorac. Dis. 2020; 12 (Suppl 1): S16–S21. PubMed Abstract | Publisher Full Text | Free Full Text 10. Sharda P, Kattupalli SC, Gajula B, et al. : Analysis of changes in blood parameter after chemotherapy in carcinoma breast: An institutional study in Northern India. Breast J. 2020 Dec 1; 26 (12): 2431–2434. PubMed Abstract | Publisher Full Text 11. Khayr W, Haddad RY, Noor SA: Infections in hematological malignancies. Dis. Mon. 2012 Apr 1; 58 (4): 239–249. Publisher Full Text 12. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. CLSI Informational Supplement M100. 32nd ed.Wayne, PA: CLSI; 2022. 13. Delgado A, Guddati AK: Infections in hospitalized cancer patients. World. J. Oncol. 2021 Dec; 12 (6): 195–205. PubMed Abstract | Publisher Full Text | Free Full Text 14. Yusuf K, Sampath V, Umar S: Bacterial infections and cancer: exploring this association and its implications for cancer patients. Int. J. Mol. Sci. 2023 Feb 4; 24 (4): 3110. PubMed Abstract | Publisher Full Text | Free Full Text 15. Amanati A, Sajedianfard S, Khajeh S, et al. : Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect. Dis. 2021 Dec; 21 : 1–4. Publisher Full Text 16. Hempel L, Piehler A, Pfaffl MW, et al. : SARS-CoV-2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy. Cancer Med. 2020 Nov; 9 (21): 8020–8028. PubMed Abstract | Publisher Full Text | Free Full Text 17. Terrones-Campos C, Ledergerber B, Specht L, et al. : Risk of bacterial, viral, and fungal infections in patients with solid malignant tumors treated with curative intent radiation therapy. Adv. Radiat. Oncol. 2022 Nov 1; 7 (6): 100950. PubMed Abstract | Publisher Full Text | Free Full Text 18. Zonneveld R, Molema G, Plötz FB: Analyzing Neutrophil Morphology, Mechanics, and Motility in Sepsis: Options and Challenges for Novel Bedside Technologies. Crit. Care Med. 2016 Jan; 44 (1): 218–228. PubMed Abstract | Publisher Full Text 19. Harada T, Harada Y, Morinaga K, et al. : Bandemia as an early predictive marker of bacteremia: A retrospective cohort study. Int. J. Environ. Res. Public Health. 2022 Feb 17; 19 (4): 2275. PubMed Abstract | Publisher Full Text | Free Full Text 20. Mare TA, Treacher DF, Shankar-Hari M, et al. : The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit. Care. 2015 Dec; 19 : 1–1. Publisher Full Text 21. Sharma S, Pratima K, Ambedkar SN, et al. : Morphological changes in white blood cells in systemic inflammatory response syndrome (SIRS) with and without sepsis: An observational study. J. Family Med. Prim. Care. 2023 Jun 1; 12 (6): 1179–1184. PubMed Abstract | Publisher Full Text | Free Full Text 22. Wang E, Boswell E, Siddiqi I, et al. : Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly. Am. J. Clin. Pathol. 2011 Feb; 135 (2): 291–303. PubMed Abstract | Publisher Full Text 23. Martinez JM, Santo AE, Ramada D, et al. : Diagnostic accuracy of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and neutrophil–lymphocyte-to-platelet ratio biomarkers in predicting bacteremia and sepsis in immunosuppressive patients with cancer: literature review. Porto Biomed. J. 2024 May 1; 9 (3): 254. PubMed Abstract | Publisher Full Text 24. Shen Y, Huang X, Zhang W: Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: interaction effect with disease severity—a retrospective study. BMJ Open. 2019 Jan 1; 9 (1): e022896. PubMed Abstract | Publisher Full Text | Free Full Text 25. Shi Y, Yang C, Chen L, et al. : Predictive value of neutrophil-to-lymphocyte and platelet ratio in in-hospital mortality in septic patients. Heliyon. 2022 Feb 17; 19 (4): 2275. 26. Zahorec R: Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy. 2001; 102 : 5–14. PubMed Abstract 27. Ye W, Chen X, Huang Y, et al. : The association between neutrophil-to-lymphocyte count ratio and mortality in septic patients: a retrospective analysis of the MIMIC-III database. J. Thorac. Dis. 2020 May; 12 (5): 1843–1855. PubMed Abstract | Publisher Full Text | Free Full Text 28. Salciccioli JD, Marshall DC, Pimentel MA, et al. : The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study. Crit. Care. 2015; 19 : 13. PubMed Abstract | Publisher Full Text | Free Full Text 29. Riche F, Gayat E, Barthelemy R, et al. : Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit. Care. 2015; 19 : 439. PubMed Abstract | Publisher Full Text | Free Full Text 30. Liu X, Shen Y, Wang H, et al. : Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study. Mediators Inflamm. 2016; 2016 : 8191254. PubMed Abstract | Publisher Full Text | Free Full Text 31. Djordjevic D, Rondovic G, Surbatovic M, et al. : Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm. 2018; 2018 : 3758068. PubMed Abstract | Publisher Full Text | Free Full Text 32. Dunn GP, Old LJ, Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004; 21 : 137–148. PubMed Abstract | Publisher Full Text 33. Seo AN, Lee HJ, Kim EJ, et al. : Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br. J. Cancer. 2013; 109 : 2705–2713. PubMed Abstract | Publisher Full Text | Free Full Text 34. Kim JY, Jung EJ, Kim JM, et al. : Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer. 2020; 20 : 1206. Publisher Full Text | ), PubMed Abstract | , Free Full Text 35. Jablonska E, Kiluk M, Markiewicz W, et al. : TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch. Immunol. Ther. Exp. 2001; 49 : 63–69. PubMed Abstract 36. Scapini P, Nesi L, Morini M, et al. : Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J. Immunol. 2002; 168 : 5798–5804. PubMed Abstract | Publisher Full Text 37. Templeton AJ, McNamara MG, Seruga B, et al. : Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2014; 106 : dju124. PubMed Abstract | Publisher Full Text 38. Hwang SY, Shin TG, Jo IJ, et al. : Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am. J. Emerg. Med. 2017; 35 : 234–239. PubMed Abstract | Publisher Full Text 39. Zahorec R: Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl. Lek. Listy. 2021 Jan 1; 122 (7): 474–488. PubMed Abstract | Publisher Full Text 40. Huang Z, Fu Z, Huang W, et al. : Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am. J. Emerg. Med. 2020; 38 : 641–647. PubMed Abstract | Publisher Full Text 41. Sridevi HB, et al. : A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units. [Dataset]. Dryad. Forthcoming 2024. Publisher Full Text Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 02 Sep 2024 ADD YOUR COMMENT Comment Author details Author details 1 Department of Pathology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India 2 Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India 3 Department of Medical Oncology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India 4 Department of General Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India Sridevi H.B. Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Anisha Maria Fernandes Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Sanyo D'souza Roles: Data Curation, Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Prashantha B. Roles: Data Curation, Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Pooja Rao Roles: Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Suchitra Shenoy M Roles: Conceptualization, Formal Analysis, Methodology, Supervision, Validation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information The author(s) declared that no grants were involved in supporting this work. Article Versions (2) version 2 Revised Published: 16 Oct 2024, 13:997 https://doi.org/10.12688/f1000research.154812.2 version 1 Published: 02 Sep 2024, 13:997 https://doi.org/10.12688/f1000research.154812.1 Copyright © 2024 H.B. S et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article H.B. S, Fernandes AM, D'souza S et al. A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.12688/f1000research.154812.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 2 VERSION 2 PUBLISHED 16 Oct 2024 Revised Views 0 Cite How to cite this report: Gupta DM. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.173195.r332383 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v2#referee-response-332383 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 05 Dec 2024 Dr Monali Gupta , Clinical Fellow, Histopathology and Haematopathology, King's College Hospital NHS Foundation Trust, London, UK Approved VIEWS 0 https://doi.org/10.5256/f1000research.173195.r332383 The authors have included all the points in this revision that I had ... Continue reading READ ALL The authors have included all the points in this revision that I had suggested earlier. The microscopic images of the peripheral smears are of good quality. Competing Interests: No competing interests were disclosed. Reviewer Expertise: Hematopathology, flow cytometry, cell counters, leukaemia, lymphoma, myeloma, MDS/MPNs, cancer genomics, AI I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Gupta DM. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.173195.r332383 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v2#referee-response-332383 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Kulkarni J. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.173195.r332382 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v2#referee-response-332382 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 21 Oct 2024 Jayashree Kulkarni , Sri Shankara Cancer Hospital and Research Centre, Bangalore, India Approved VIEWS 0 https://doi.org/10.5256/f1000research.173195.r332382 I have gone through the revised version and found satisfactory implementation of my comments on the first version. Kindly correct the spelling of anomaly in the discussion section in the following sentence "Presence of PPHA may pose diagnostic challenge in ... Continue reading READ ALL I have gone through the revised version and found satisfactory implementation of my comments on the first version. Kindly correct the spelling of anomaly in the discussion section in the following sentence "Presence of PPHA may pose diagnostic challenge in patients with history of cancer therapy and associated cytopenias to differentiate from myelodysplastic neoplasm associated Pelger-Huet anamoly " Competing Interests: No competing interests were disclosed. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Kulkarni J. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.173195.r332382 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v2#referee-response-332382 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 24 Oct 2024 Anisha Maria Fernandes , Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India 24 Oct 2024 Author Response Thank you for your comments. Will make the necessary changes. Competing Interests: No competing interests were disclosed. Thank you for your comments. Will make the necessary changes. Thank you for your comments. Will make the necessary changes. Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 24 Oct 2024 Anisha Maria Fernandes , Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India 24 Oct 2024 Author Response Thank you for your comments. Will make the necessary changes. Competing Interests: No competing interests were disclosed. Thank you for your comments. Will make the necessary changes. Thank you for your comments. Will make the necessary changes. Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Version 1 VERSION 1 PUBLISHED 02 Sep 2024 Views 0 Cite How to cite this report: Gupta DM. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.169886.r322615 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v1#referee-response-322615 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 01 Oct 2024 Dr Monali Gupta , Clinical Fellow, Histopathology and Haematopathology, King's College Hospital NHS Foundation Trust, London, UK Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.169886.r322615 The article is well written in simple and clear words. It does say that it is a prospective study but it does not mention the time period of the study undertaken as the size of the study is small. It ... Continue reading READ ALL The article is well written in simple and clear words. It does say that it is a prospective study but it does not mention the time period of the study undertaken as the size of the study is small. It would be good to mention in the introduction. In the methods and analysis, the authors have mentioned that they have used DXH800 haematology analyser from Beckman Coulter. This analyser provides Immature granulocyte % fairly accurately. Have the authors taken the IG% from the analyser in the study or have they calculated it manually from the peripheral smears? Worth a mention in the article. Reading and interpreting a peripheral smear is a skill and requires training. It is prudent to distinguish the toxic granules in the neutrophils due to infection or due to G-CSF in cancer patients. Has this been addressed? I would also recommend to include some pictures of the peripheral smears showing left shift, toxic granulations, cytoplasmic vacuolations, reactive lymphocytes, aspergillosis. Are neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios validated sepsis parameters in a clinical setting? It would be worth clarifying about these with supporting literature as many of them are still research parameters? I found this statement quite intriguing - "In solid malignancies, NLR and PLR parameters can be utilized in correlation with tumor size node-metastasis (TNM) staging." Can the authors throw light on this statement and cite the reference from where it is taken? I think the article should be accepted for indexing with the above clarifications and recommendations. Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Hematopathology, flow cytometry, cell counters, leukaemia, lymphoma, myeloma, MDS/MPNs, cancer genomics, AI I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Gupta DM. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.169886.r322615 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v1#referee-response-322615 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 16 Oct 2024 Anisha Maria Fernandes , Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India 16 Oct 2024 Author Response Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules ... Continue reading Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 16 Oct 2024 Anisha Maria Fernandes , Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India 16 Oct 2024 Author Response Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules ... Continue reading Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Kulkarni J. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.169886.r322608 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v1#referee-response-322608 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 23 Sep 2024 Jayashree Kulkarni , Sri Shankara Cancer Hospital and Research Centre, Bangalore, India Approved VIEWS 0 https://doi.org/10.5256/f1000research.169886.r322608 The authors have, in a very simple way created awareness of the importance of accurate diagnosis of infections using basic tools like CBC and its components (ANC, ALC, NLR and PLR). These are available in a most basic laboratory and ... Continue reading READ ALL The authors have, in a very simple way created awareness of the importance of accurate diagnosis of infections using basic tools like CBC and its components (ANC, ALC, NLR and PLR). These are available in a most basic laboratory and can be implemented without much difficulty. As far as peripheral smear examination is concerned, it may be difficult and labor intensive, especially in high volume cancer care centers. I suggest the authors include "other mimics of left shift should be ruled out like: 1. G-CSF (very commonly used in neutropenic patients) induced changes which also show course granulations and can be mistaken for toxic granules 2. Taxane induced Pseudo-Pelger Huet anomaly, which many may not be aware of. The language/grammar is very lucid. Adequate and appropriate references are provided. The article may be accepted for indexing with above mentioned suggestions. Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Hematopathology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Kulkarni J. Reviewer Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.169886.r322608 ) The direct URL for this report is: https://f1000research.com/articles/13-997/v1#referee-response-322608 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 16 Oct 2024 Anisha Maria Fernandes , Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India 16 Oct 2024 Author Response Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. Competing Interests: No competing interests were disclosed. Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 16 Oct 2024 Anisha Maria Fernandes , Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India 16 Oct 2024 Author Response Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. Competing Interests: No competing interests were disclosed. Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 02 Sep 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 2 (revision) 16 Oct 24 read read Version 1 02 Sep 24 read read Jayashree Kulkarni , Sri Shankara Cancer Hospital and Research Centre, Bangalore, India Dr Monali Gupta , King's College Hospital NHS Foundation Trust, London, UK Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Gupta D. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 05 Dec 2024 | for Version 2 Dr Monali Gupta , Clinical Fellow, Histopathology and Haematopathology, King's College Hospital NHS Foundation Trust, London, UK 0 Views copyright © 2024 Gupta D. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The authors have included all the points in this revision that I had suggested earlier. The microscopic images of the peripheral smears are of good quality. Competing Interests No competing interests were disclosed. Reviewer Expertise Hematopathology, flow cytometry, cell counters, leukaemia, lymphoma, myeloma, MDS/MPNs, cancer genomics, AI I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Gupta DM. Peer Review Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.173195.r332383) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-997/v2#referee-response-332383 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Kulkarni J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 21 Oct 2024 | for Version 2 Jayashree Kulkarni , Sri Shankara Cancer Hospital and Research Centre, Bangalore, India 0 Views copyright © 2024 Kulkarni J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions I have gone through the revised version and found satisfactory implementation of my comments on the first version. Kindly correct the spelling of anomaly in the discussion section in the following sentence "Presence of PPHA may pose diagnostic challenge in patients with history of cancer therapy and associated cytopenias to differentiate from myelodysplastic neoplasm associated Pelger-Huet anamoly " Competing Interests No competing interests were disclosed. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (1) Author Response 24 Oct 2024 Anisha Maria Fernandes, Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India Thank you for your comments. Will make the necessary changes. View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Kulkarni J. Peer Review Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.173195.r332382) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-997/v2#referee-response-332382 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Gupta D. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 01 Oct 2024 | for Version 1 Dr Monali Gupta , Clinical Fellow, Histopathology and Haematopathology, King's College Hospital NHS Foundation Trust, London, UK 0 Views copyright © 2024 Gupta D. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The article is well written in simple and clear words. It does say that it is a prospective study but it does not mention the time period of the study undertaken as the size of the study is small. It would be good to mention in the introduction. In the methods and analysis, the authors have mentioned that they have used DXH800 haematology analyser from Beckman Coulter. This analyser provides Immature granulocyte % fairly accurately. Have the authors taken the IG% from the analyser in the study or have they calculated it manually from the peripheral smears? Worth a mention in the article. Reading and interpreting a peripheral smear is a skill and requires training. It is prudent to distinguish the toxic granules in the neutrophils due to infection or due to G-CSF in cancer patients. Has this been addressed? I would also recommend to include some pictures of the peripheral smears showing left shift, toxic granulations, cytoplasmic vacuolations, reactive lymphocytes, aspergillosis. Are neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios validated sepsis parameters in a clinical setting? It would be worth clarifying about these with supporting literature as many of them are still research parameters? I found this statement quite intriguing - "In solid malignancies, NLR and PLR parameters can be utilized in correlation with tumor size node-metastasis (TNM) staging." Can the authors throw light on this statement and cite the reference from where it is taken? I think the article should be accepted for indexing with the above clarifications and recommendations. Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Hematopathology, flow cytometry, cell counters, leukaemia, lymphoma, myeloma, MDS/MPNs, cancer genomics, AI I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (1) Author Response 16 Oct 2024 Anisha Maria Fernandes, Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India Thank you for your valuable inputs. We have addressed your comments regarding: Study period. Method of calculation of immature granulocyte %. Differentiation of toxic granules in the neutrophils due to infection or due to G-CSF. Peripheral smears showing toxic granulations, left shift and toxic vacuolation in neutrophils. Discussion and reference on utility of NLR and PLR as biomarkers of sepsis. Clarification and reference for utilization of NLR and PLR parameters in correlation with tumor size node-metastasis (TNM) staging in solid malignancies. View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Gupta DM. Peer Review Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.169886.r322615) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-997/v1#referee-response-322615 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Kulkarni J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 23 Sep 2024 | for Version 1 Jayashree Kulkarni , Sri Shankara Cancer Hospital and Research Centre, Bangalore, India 0 Views copyright © 2024 Kulkarni J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The authors have, in a very simple way created awareness of the importance of accurate diagnosis of infections using basic tools like CBC and its components (ANC, ALC, NLR and PLR). These are available in a most basic laboratory and can be implemented without much difficulty. As far as peripheral smear examination is concerned, it may be difficult and labor intensive, especially in high volume cancer care centers. I suggest the authors include "other mimics of left shift should be ruled out like: 1. G-CSF (very commonly used in neutropenic patients) induced changes which also show course granulations and can be mistaken for toxic granules 2. Taxane induced Pseudo-Pelger Huet anomaly, which many may not be aware of. The language/grammar is very lucid. Adequate and appropriate references are provided. The article may be accepted for indexing with above mentioned suggestions. Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Hematopathology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (1) Author Response 16 Oct 2024 Anisha Maria Fernandes, Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 576104, India Thank you for your valuable inputs. We have addressed your comment regarding: Mimics of left shift such as G-CSF and Taxane induced Pseudo-Pelger Huet anomaly. View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Kulkarni J. Peer Review Report For: A practical approach to febrile cancer patients: Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved] . F1000Research 2024, 13 :997 ( https://doi.org/10.5256/f1000research.169886.r322608) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-997/v1#referee-response-322608 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "A practical approach to febrile cancer patients:\u00A0...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/13-997/v2" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/13-997/v2&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/13-997/v2" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('H.B. S et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/13-997/v2/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/13-997", templates : { twitter : "A practical approach to febrile cancer patients:\u00A0 Diagnostic.... H.B. S et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/13-997/v2" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/154812/173195") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "173195"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "320396": 0, "320397": 0, "320398": 0, "320399": 0, "320392": 0, "320393": 0, "320394": 0, "320395": 0, "320400": 0, "320401": 0, "341916": 0, "341915": 0, "341914": 0, "322607": 0, "322612": 0, "322613": 0, "322614": 0, "322615": 13, "322608": 11, "322609": 0, "322610": 0, "322611": 0, "322616": 0, "333133": 0, "345165": 0, "333132": 0, "345164": 0, "333135": 0, "339151": 0, "345167": 0, "333134": 0, "339150": 0, "345166": 0, "333129": 0, "345161": 0, "345160": 0, "333131": 0, "345163": 0, "333130": 0, "345162": 0, "339157": 0, "339156": 0, "339159": 0, "339158": 0, "333137": 0, "339153": 0, "345169": 0, "333136": 0, "339152": 0, "345168": 0, "339155": 0, "333138": 0, "339154": 0, "332383": 9, "332382": 8, "336231": 0, "336230": 0, "336237": 0, "336236": 0, "336239": 0, "336238": 0, "336233": 0, "336232": 0, "336235": 0, "336234": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "ba763bd9-a544-4df3-ab52-df185f578f3c"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });